|
Eiko Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
74.63 Cr.
|
P/BV
|
1.32
|
Book Value (Rs.)
|
41.36
|
|
52 Week High/Low (Rs.)
|
75/42
|
FV/ML
|
10/1
|
P/E(X)
|
35.46
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
1.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 3.06 | -4.93 | -1.00 | 0.00 |
| | | | | |
| Net CashFlow From Operating Activities | 2.92 | -0.33 | 0.16 | 0.00 |
| Net Cash Used In Investing Activities | -11.44 | -0.71 | -0.30 | 0.00 |
| Net Cash Used From Financing Activities | 6.96 | 0.95 | -0.55 | 0.00 |
| | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.57 | -0.09 | -0.69 | 0.00 |
| Cash And Cash Equivalents Begin of Year | 13.35 | 0.11 | 0.80 | 0.00 |
| Cash And Cash Equivalents End Of Year | 11.78 | 0.02 | 0.11 | 0.00 |
